Internal Medicine, Rheumatology · San Francisco, CA
NPI
1326210055
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
1455 Leavenworth St Apt 304
San Francisco, CA, 94109
Phone (415) 447-9246
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,472
21 services
Medicare patients, 2024
12
Average age 66
Drug cost, 2024
$1.9M
2,684 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Karen C Yeter prescribed most often to Medicare patients was Prednisone, with 473 prescriptions and refills. In total Karen C Yeter wrote 2,684 Medicare prescriptions that cost $1.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prednisone Generic | 473 | 1,130 | 220 | $5,131 |
| Methotrexate Methotrexate Sodium | 429 | 1,287 | 215 | $9,340 |
| Hydroxychloroquine Sulfate Generic | 284 | 890 | 147 | $9,212 |
| Leflunomide Generic | 147 | 448 | 69 | $4,545 |
| Rasuvo Methotrexate/Pf | 127 | 177 | 41 | $72K |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 107 | 109 | 21 | $99K |
| Allopurinol Generic | 98 | 310 | 44 | $1,169 |
| Enbrel Sureclick Etanercept | 90 | 90 | 18 | $439K |
| Enbrel Etanercept | 70 | 70 | 17 | $334K |
| Sulfasalazine Generic | 68 | 205 | 36 | $4,599 |
| Colchicine Generic | 59 | 141 | 32 | $1,786 |
| Xeljanz Tofacitinib Citrate | 55 | 60 | 14 | $149K |
| Tramadol Hcl Generic | 48 | 48 | 27 | $417 |
| Ibuprofen Generic | 46 | 54 | 24 | $666 |
| Rinvoq Upadacitinib | 39 | 39 | Under 11 | $206K |
Brand drugs: - claims; generic drugs: 1,942 claims; opioid claims: 82.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Karen C Yeter were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.